𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of 36 novel Jagged1 (JAG1) mutations in patients with Alagille syndrome

✍ Scribed by Albrecht Röpke; Annegret Kujat; Mechthild Gräber; Joannis Giannakudis; Ingo Hansmann


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
37 KB
Volume
21
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Alagille syndrome (AGS) is an autosomal dominant disorder characterized by five major symptoms: cholestasis, vertebral deformity, heart malformations, ocular defects and peculiar facial appearance. The previously described Jagged1 (JAG1) gene on chromosome 20p12 has been identified as being responsible for AGS. JAG1 encodes a transmembrane protein acting as ligand for the evolutionarily conserved Notch signaling pathway. Here we report 36 novel mutations in the JAG1 gene. We identified 12 novel deletions, 4 insertions, 8 missense, 7 nonsense and 5 splice site mutations. All mutations map to the sequence encoding the extracellular part of the Jagged1 protein. The mutations spread over the entire gene with slightly increased rates in exons 2 to 6 and exon 23 and 24. Eight novel missense mutations map to the Delta-Serrate-Lag2 (DSL) domain and adjacent sequences which are important for ligand-receptor interaction. Inheritance was determined in 27 families. Sixteen mutations (55%) were de novo and eleven mutations (45%) were transmitted. Altogether 226 different JAG1 mutations have been described in association with AGS, including our novel 36 mutations. AGS variants are spread over the entire gene with only a few mutations in exon 26. A relatively high number of mutations are clustered in exons 2 to 6. This sequence region shows high interspecies conservation and encodes the Notch receptor-binding region (DSL domain).


📜 SIMILAR VOLUMES


Mutation analysis of Jagged1 (JAG1) in A
✍ Raymond P. Colliton; Lynn Bason; Feng-Min Lu; David A. Piccoli; Ian D. Krantz; N 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Alagille syndrome (AGS) is an autosomal dominant disorder caused by mutations in Jagged1 (JAG1), a ligand in the evolutionarily conserved Notch signaling pathway. Previous studies have demonstrated that a wide spectrum of JAG1 mutations result in AGS. These include total gene deletions, protein trun

Jagged1 mutations in Alagille syndrome
✍ Nancy B. Spinner; Raymond P. Colliton; Cécile Crosnier; Ian D. Krantz; Michelle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views
DHPLC mutation analysis of Jagged1 (JAG1
✍ Mandy L. Heritage; John C. MacMillan; Gregory J. Anderson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Alagille syndrome (AGS) is an autosomal dominant disorder characterized by abnormal development of the liver, heart, skeleton, eye, and face. Mutations in the Jagged1 gene have been found to result in the AGS phenotype. Using denaturing high performance liquid chromatography (DHPLC) mutation analysi

Jagged-1 mutation analysis in Italian Al
✍ Giuseppe Pilia; Manuela Uda; Dolores Macis; Fulvia Frau; Laura Crisponi; Fiorell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

## Communicated by Riccardo Fodde Alagille syndrome (AGS) is an autosomal dominant disorder with developmental abnormalities affecting the liver, heart, eyes, vertebrae, and craniofacial region. The Jagged-1 (JAG1) gene, which encodes a ligand of Notch, has recently been found mutated in AGS. In th

Jagged1 (JAG1) mutations in Alagille syn
✍ DM Warthen; EC Moore; BM Kamath; JJD Morrissette; P Sanchez; DA Piccoli; ID Kran 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Alagille syndrome (AGS) is caused by heterozygous mutations in JAG1, and mutations have been previously reported in about 70% of patients who meet clinical diagnostic criteria. We studied a cohort of 247 clinically well-defined patients, and using an aggressive and sequential screening approach we i